Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
UBS
Boehringer Ingelheim
Express Scripts
Johnson and Johnson
McKesson
Daiichi Sankyo
Citi
Medtronic

Generated: May 24, 2018

DrugPatentWatch Database Preview

MILONTIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Milontin patents expire, and when can generic versions of Milontin launch?

Milontin is a drug marketed by Parke Davis and is included in one NDA.

The generic ingredient in MILONTIN is phensuximide. Additional details are available on the phensuximide profile page.
Summary for MILONTIN
Drug patent expirations by year for MILONTIN
Synonyms for MILONTIN
(.+/-.)-N-Methyl-2-phenylsuccinimide
(+-)-N-Methyl-2-phenylsuccinimide
(+/-)-N-Methyl-2-phenylsuccinimide
086P340
1-Methyl-3-phenyl-2,5-pyrrolidinedione
1-Methyl-3-phenyl-2,5-pyrrolidinedione #
1-Methyl-3-phenylpyrrolidin-2,5-dione
1-methyl-3-phenylpyrrolidine-2,5-dione
1-Methyl-3-Phenylsuccinimide
2,5-Pyrrolidinedione, 1-methyl-3-phenyl-
2,5-Pyrrolidinedione, 1-methyl-3-phenyl-, (+-)-
5-21-11-00188 (Beilstein Handbook Reference)
7 Phenosuccimide
86-34-0
97233-03-9
97233-04-0
AB00514025
AB00514025_07
AC-15962
AC1L1NF1
ACMC-20m1g5
ACMC-20m1g6
AI3-20372
AKOS006230701
API0009009
BPBio1_001148
BRD-A18043272-001-03-2
BRN 0155329
BSPBio_001042
C07437
CAS-86-34-0
CCG-213454
CHEBI:8079
CHEMBL797
D00508
D06BYV
DB00832
DSSTox_CID_3460
DSSTox_GSID_23460
DSSTox_RID_77035
DTXSID4023460
EINECS 201-664-6
EN300-221563
Epimid
FCH2092775
Fenosuccimide
Fensuccimide
Fensuccimide [DCIT]
Fensuximida
Fensuximida [INN-Spanish]
GTPL7612
HE040709
HE398357
HMS1571E04
HMS2098E04
HMS2235H10
HMS3264E08
HMS3369L21
Lifen
Lifene
LS-147620
Methylphenylsuccinimide
Milontin (TN)
Milonton
Mirontin
Mirotin
MLS002154134
N-Methyl-.alpha.-phenylsuccinimide
N-METHYL-2-PHENYL SUCCINIMIDE
N-Methyl-2-phenylsuccinimide
N-Methyl-alpha-phenolsuccinimide
N-Methyl-alpha-phenylsuccinimide
NCGC00016339-01
NCGC00179333-01
NCGC00179333-03
NSC-760079
NSC760079
Pharmakon1600-01505458
phensuccimide
Phensuximid
Phensuximide
Phensuximide (USP)
Phensuximide (USP/INN)
Phensuximide [BAN:INN]
Phensuximide [INN:BAN]
Phensuximide [USP:INN:BAN]
Phensuximidum
Phensuximidum [INN-Latin]
Phenylsuximide
PM 334
Prestwick0_001061
Prestwick1_001061
Prestwick2_001061
Prestwick3_001061
racemic phensuximide
RS-Phensuximide
RTECS WV0994000
SCHEMBL35333
SMR001233441
SPBio_002961
SR-01000842158
SR-01000842158-2
Succinimide, N-methyl-2-phenyl-
Succitimal
Tox21_110382
Tox21_110382_1
WLWFNJKHKGIJNW-UHFFFAOYSA-N

US Patents and Regulatory Information for MILONTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis MILONTIN phensuximide CAPSULE;ORAL 008855-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Medtronic
Mallinckrodt
Queensland Health
Citi
Deloitte
Colorcon
Cerilliant
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.